(VIANEWS) – Annaly Capital (NLY), Jiayin Group (JFIN), CBAK Energy Technology (CBAT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Annaly Capital (NLY)
29% sales growth and 14.06% return on equity
Annaly Capital Management, Inc., a diversified capital manager, engages in mortgage finance and corporate middle market lending. The company invests in agency mortgage-backed securities, mortgage servicing rights, Agency commercial mortgage-backed securities, non-Agency residential mortgage assets, residential mortgage loans, credit risk transfer securities, corporate debts, and other commercial real estate investments. It has elected to be taxed as a real estate investment trust (REIT). As a REIT, it is not subject to federal income tax to the extent that it distributes its taxable income to its shareholders. The company was founded in 1996 and is based in New York, New York.
Earnings Per Share
As for profitability, Annaly Capital has a trailing twelve months EPS of $3.1.
PE Ratio
Annaly Capital has a trailing twelve months price to earnings ratio of 5.94. Meaning, the purchaser of the share is investing $5.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.06%.
Sales Growth
Annaly Capital’s sales growth is 20.9% for the present quarter and 29% for the next.
Moving Average
Annaly Capital’s worth is way under its 50-day moving average of $21.54 and way under its 200-day moving average of $22.47.
2. Jiayin Group (JFIN)
26.3% sales growth and 259.74% return on equity
Jiayin Group Inc. operates as an online individual finance platform that connects individual investors and individual borrowers in China. It operates a secure and open platform that facilitates transparent, secure, and fast connections between investors and borrowers. The company was founded in 2011 and is based in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Jiayin Group has a trailing twelve months EPS of $2.03.
PE Ratio
Jiayin Group has a trailing twelve months price to earnings ratio of 1.44. Meaning, the purchaser of the share is investing $1.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 259.74%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Jiayin Group’s EBITDA is 0.29.
3. CBAK Energy Technology (CBAT)
20.5% sales growth and 8.05% return on equity
CBAK Energy Technology, Inc., through its subsidiaries, develops, manufactures, and sells lithium batteries in Mainland China, the United States, Europe, Taiwan, Israel, and internationally. Its products are used in various applications, including electric vehicles, such as electric cars, electric buses, and hybrid electric cars and buses; light electric vehicles that include electric bicycles, electric motors, and sight-seeing cars; and electric tools, energy storage, uninterruptible power supply, and other high power applications, as well as cordless power tools. The company was formerly known as China BAK Battery, Inc. and changed its name to CBAK Energy Technology, Inc. in January 2017. CBAK Energy Technology, Inc. was founded in 1999 and is based in Dalian, China.
Earnings Per Share
As for profitability, CBAK Energy Technology has a trailing twelve months EPS of $-0.126.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.05%.
Volume
Today’s last reported volume for CBAK Energy Technology is 98537 which is 39.31% below its average volume of 162381.
Sales Growth
CBAK Energy Technology’s sales growth for the next quarter is 20.5%.
Moving Average
CBAK Energy Technology’s value is under its 50-day moving average of $1.08 and way under its 200-day moving average of $1.18.
4. Globus Medical (GMED)
6.6% sales growth and 10.6% return on equity
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Earnings Per Share
As for profitability, Globus Medical has a trailing twelve months EPS of $1.77.
PE Ratio
Globus Medical has a trailing twelve months price to earnings ratio of 30.8. Meaning, the purchaser of the share is investing $30.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.6%.
Previous days news about Globus Medical(GMED)
- According to Zacks on Friday, 17 March, "NuVasive’s (NUVA Quick QuoteNUVA – Free Report) impending merger with Globus Medical (GMED Quick QuoteGMED – Free Report) seems strategically aligned with the company’s business. ", "Per the terms of the agreement, which was unanimously approved by the boards of directors of both companies, NuVasive shareholders will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock owned at the close of the transaction. "
5. Barrett Business Services (BBSI)
6.2% sales growth and 24.47% return on equity
Barrett Business Services, Inc. provides business management solutions for small and mid-sized companies in the United States. The company develops a management platform that integrates a knowledge-based approach from the management consulting industry with tools from the human resource outsourcing industry. It offers professional employer services under which it enters into a client services agreement to establish a co-employment relationship with each client company, assuming responsibility for payroll, payroll taxes, workers' compensation coverage, and other administration functions for the client's existing workforce. The company also provides staffing and recruiting services, such as on-demand or short-term staffing assignment, contract staffing, direct placement, and long-term or indefinite-term on-site management services. It serves electronics manufacturers, light-manufacturing industries, agriculture-based companies, transportation and shipping enterprises, food processors, telecommunications companies, public utilities, general contractors in various construction-related fields, and professional services firms. The company was incorporated in 1965 and is headquartered in Vancouver, Washington.
Earnings Per Share
As for profitability, Barrett Business Services has a trailing twelve months EPS of $6.42.
PE Ratio
Barrett Business Services has a trailing twelve months price to earnings ratio of 13.59. Meaning, the purchaser of the share is investing $13.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.47%.
Sales Growth
Barrett Business Services’s sales growth is 5.5% for the present quarter and 6.2% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6%, now sitting on 1.05B for the twelve trailing months.
